NPS Pharma CEO: Do not need to raise cash

Wednesday, 11 Sep 2013 | 6:15 PM ET

NPS Pharmaceuticals is a developer of orphan drugs for ultra-rare diseases, and its stock has been on a tear for 6 months. Its CEO Dr. Francois Nader discusses its latest trials and FDA approvals.